Literature DB >> 31713487

Chronic Stress and Diabetes Mellitus: Interwoven Pathologies.

Vivek Kumar Sharma1,2, Thakur Gurjeet Singh1.   

Abstract

Stress threatens the homeostasis and mobilizes a plethora of adaptive physiological and behavioral changes via the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system. The HPA axis influences the pituitary gland, hypothalamus and adrenal gland via a complex set of positive and negative feedback system. The feedback system operates in a well regulated neuroendocrine manner to reestablish the threatened body equilibrium. The HPA axis secreted major product is a glucocorticoid (cortisol) which is kept within a physiologically optimal range and serves to accomplish the various physiological functions crucial for survival. In chronically stressed individuals dishabituation of HPA axis is followed by increased release of glucocorticoids and catecholamines. Higher secretion of glucocorticoids influences glucose metabolism by promoting gluconeogenesis in the liver, suppressing glucose uptake (adipocytes and skeletal muscles), promoting lipolysis in adipocytes, suppressing insulin secretion, inflicting insulin resistance and inflammation. These biological changes alter neuroendocrine mechanisms and lead to maladaptive congregation of events that form the underlying cause of development of Type 2 diabetes (T2D). The currently reviewed evidences advocate that targeting stress mediated hypersecretion of glucocorticoids may be a viable approach for the treatment of T2D and to reinstate glucose homeostasis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Chronic stress; diabetes; glucocorticoids; hypothalamic-pituitary-adrenal axis; inflammation; insulin.

Year:  2020        PMID: 31713487     DOI: 10.2174/1573399815666191111152248

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  8 in total

Review 1.  Kynurenine Metabolism and Alzheimer's Disease: The Potential Targets and Approaches.

Authors:  Vivek Kumar Sharma; Thakur Gurjeet Singh; Nirbhay Kumar Prabhakar; Ashi Mannan
Journal:  Neurochem Res       Date:  2022-02-08       Impact factor: 3.996

Review 2.  Diabetic Muscular Atrophy: Molecular Mechanisms and Promising Therapies.

Authors:  Yuntian Shen; Ming Li; Kexin Wang; Guangdong Qi; Hua Liu; Wei Wang; Yanan Ji; Mengyuan Chang; Chunyan Deng; Feng Xu; Mi Shen; Hualin Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

Review 3.  Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential.

Authors:  Vivek Kumar Sharma; Thakur Gurjeet Singh; Shareen Singh; Nikhil Garg; Sonia Dhiman
Journal:  Neurochem Res       Date:  2021-08-12       Impact factor: 3.996

4.  Longitudinal association of midlife vision impairment and depressive symptoms: the study of Women's Health Across the Nation, Michigan site.

Authors:  Carrie A Karvonen-Gutierrez; Navasuja Kumar; Michelle M Hood; David C Musch; Sioban Harlow; Sayoko E Moroi
Journal:  Menopause       Date:  2021-10-25       Impact factor: 3.310

Review 5.  Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination.

Authors:  Rupinder Kaur; Shareen Singh; Thakur Gurjeet Singh; Pragati Sood; Jiki Robert
Journal:  Inflammopharmacology       Date:  2022-01-03       Impact factor: 5.093

Review 6.  Diabetes and associated cognitive disorders: Role of the Hypothalamic-Pituitary Adrenal axis.

Authors:  Nathalie Marissal-Arvy; Marie-Pierre Moisan
Journal:  Metabol Open       Date:  2022-07-31

7.  Arctostaphylos uva-ursi L. leaves extract and its modified cysteine preparation for the management of insulin resistance: chemical analysis and bioactivity.

Authors:  Ganna Kravchenko; Oksana Krasilnikova; Ain Raal; Matar Mazen; Natalia Chaika; Igor Kireyev; Andriy Grytsyk; Oleh Koshovyi
Journal:  Nat Prod Bioprospect       Date:  2022-08-12

Review 8.  Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment.

Authors:  Chujun Deng; Huize Chen; Zeyu Meng; Shengxi Meng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-21       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.